PapersPMID:15674878
Glutamine supplementation to prevent morbidity and mortality in preterm infants.
- findings
- 2
- compound
- 1
- endpoints
- 2
L-glutamine- Study, every finding
- meta-analysis
- Population, every finding
- very low birth weight preterm infants (pooled meta-analysis of six randomised trials, enteral and parenteral)
No finding here moved its endpoint.
What did not
How to read these marks →“We found that glutamine supplementation does not have a statistically significant effect on the incidence of systemic infection (typical relative risk 1.02 (95% confidence interval 0.92 to 1.13); typical risk difference 0.01 (95% confidence interval -0.03 to 0.05)), necrotising enterocolitis (typical relative risk 1.02 (95% confidence interval 0.79 to 1.33); typical risk difference 0.00 (95% confidence interval -0.02 to 0.03)), days to full enteral nutrition (weighted mean difference -1.1 days (95% confidence interval -3.4 to 1.2)), or duration of hospital stay (weighted mean difference 0.65 days (95% confidence interval -2.9 to 4.2)).”
- Effect
- 1.02 risk ratio, 95% CI 0.79 to 1.33
- No detected effect on hospital length of stay
very limitedreplicated ×2
- Effect
- 0.65 mean difference, 95% CI −2.9 to 4.2
Study record
- Design
- meta-analysis
- Species
- human
- Population
- very low birth weight preterm infants, birth to hospital discharge (pooled meta-analysis of six randomised trials, enteral and parenteral)
- Participants
- 2,300
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 6